Inhibitors of serine proteases
    6.
    发明授权
    Inhibitors of serine proteases 失效
    丝氨酸蛋白酶抑制剂

    公开(公告)号:US08575208B2

    公开(公告)日:2013-11-05

    申请号:US12528952

    申请日:2008-02-20

    IPC分类号: A61K31/4025 C07D207/08

    CPC分类号: C07D487/10 C07D498/10

    摘要: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention.

    摘要翻译: 本发明涉及抑制丝氨酸蛋白酶活性,特别是丙型肝炎病毒NS3-NS4A蛋白酶活性的化合物。 因此,它们通过干扰丙型肝炎病毒的生命周期起作用,也可用作抗病毒剂。 本发明还涉及包含这些化合物的组合物,用于离体使用或给予患有HCV感染的患者。 本发明还涉及通过施用包含本发明化合物的组合物来治疗患者HCV感染的方法。